Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction.

Christersson, C

Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction. [electronic resource] - Journal of internal medicine Sep 2011 - 215-23 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-2796

10.1111/j.1365-2796.2011.02354.x doi


Administration, Oral
Aged
Aged, 80 and over
Antithrombins--administration & dosage
Aspirin--administration & dosage
Azetidines--administration & dosage
Benzylamines--administration & dosage
Biomarkers--blood
Blood Platelets--drug effects
C-Reactive Protein--metabolism
Comorbidity
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Inflammation--blood
Interleukin-10--blood
Interleukin-18--blood
Male
Middle Aged
Myocardial Infarction--blood
P-Selectin--blood
Platelet Activation--drug effects
Risk Factors
Thromboplastin--metabolism
Time Factors
Treatment Outcome